One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood.v130.suppl_1.650.650
Copy DOI Journal: Blood |  Publication Date: Dec 7, 2017 |
 Citations: 10 |
Affiliation: Bristol-Myers Squibb (United States), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Memorial Sloan Kettering Cancer Center, Los Angeles Medical Center, Mayo Clinic, Dana-Farber Cancer Institute, Karmanos Cancer Institute, Churchill Hospital, General University Hospital in Prague, Princess Margaret Cancer Centre, University of Toronto, University Hospital Cologne, Emory University, BC Cancer Agency, University of Bologna, The University of Texas MD Anderson Cancer Center, Humanitas UniversityNivolumab Treatment Beyond Investigator-Assessed Progression: Outcomes in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma from the Phase 2 Checkmate 205 Study
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
